Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918606 · ClinicalTrials.gov registry record · Phase 1
An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
A Phase 1 study, sponsored by Neothetics.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00918606 is a Phase 1 study that has completed, run by Neothetics. The registered enrollment target is 30 participants.
The verdict
NCT00918606, a Phase 1 study, has completed, sponsored by Neothetics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.
Interventions
- DRUG LIPO-102
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918606
The ClinicalTrials.gov registry entry for NCT00918606 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neothetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LIPO-102 is the first listed.
NCT00918606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918606 about?
NCT00918606 is a clinical study titled "An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers". An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.
What is the current status of trial NCT00918606?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00918606?
The interventions under investigation include: LIPO-102 (DRUG).
Who is sponsoring clinical trial NCT00918606?
This trial is sponsored by Neothetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.